Skip to main content
Log in

Gastric and duodenal carcinoid tumours. Prevalence, tumour biology, diagnosis and surgical therapy

  • Review Article
  • Published:
Hellenic Journal of Surgery

Abstract

Carcinoid tumours is the most accepted term for neuroendocrine tumours, or neuroendocrine carcinomas. Gastric and duodenal carcinoid tumours, though rare, have been the focus of much scientific investigation. These neoplasms pose a diagnostic and therapeutic challenge. Despite the latest available therapies, the incidence of gastric carcinoid appears to be rising, mostly due to the increased application of gastroscopy, without a corresponding increase in survival. Subtyping of gastric and duodenal carcinoids (four types, according to their origin and histologic variations) is helpful in the prediction of malignant potential and long-term survival and as a guide to management. Advances in our understanding of the pathogenesis of gastric carcinoids and associate diseases have led to recent improvements in investigation and management. Surgery remains the main curative modality.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Pasieka J. Carcinoid tumors. Surg Clin N Am 2009;89:1123–1137.

    Article  PubMed  Google Scholar 

  2. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003;97:934–959.

    Article  PubMed  Google Scholar 

  3. Kulke M, Mayer R. Carcinoid tumors. N Engl J Med 1999;340:858–868.

    Article  PubMed  CAS  Google Scholar 

  4. Gustafsson BI, Kidd M, Modlin IM. Neuroendocrine tumors of the diffuse neuroendocrine system. Curr Opin Oncol 2008;20:1–12.

    Article  PubMed  Google Scholar 

  5. Arnold R. Endocrine tumours of the gastrointestinal tract. Introduction: definition, historical aspects, classification, staging, prognosis and therapeutic options. Best Pract Res Clin Gastroenterol 2005;19:491–505.

    Article  PubMed  CAS  Google Scholar 

  6. Oberg K. Diagnosis and treatment of carcinoid tumors. Expert Rev Anticancer Ther 2003;3:863–877.

    Article  PubMed  Google Scholar 

  7. Van Eeden S, Quaedvlieg PF, Taal BG, Offerhaus GJ, Lamers CB, Van Velthuysen ML. Classification of low-grade neuroendocrine tumors of midgut and unknown origin. Hum Pathol 2002;33:1126–1132.

    Article  PubMed  Google Scholar 

  8. Dayal Y. Gl-NETs-uniform but also diverse. Endocr Pathol 2007;18:135–140.

    Article  PubMed  Google Scholar 

  9. Modlin IM, Oberg K, Chung DC, Jensen RT, de Herder WW, Thakker RV, Caplin M, Delle Fave G, Kaltsas GA, Krenning EP, Moss SF, Nilsson O, Rindi G, Salazar R, Ruszniewski P, Sundin A. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol 2008;9:61–72.

    Article  PubMed  CAS  Google Scholar 

  10. Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A, Evans DB. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 2008 2008;26:3063–3072.

    Article  Google Scholar 

  11. Akerstrom G, Hellman P. Surgery on neuroendocrine tumours. Best Pract Res Clin Endocrinol Metab 2007;21:87–109.

    Article  PubMed  Google Scholar 

  12. Granberg D, Oberg K. Neuroendocrine tumours. Cancer Chemother Biol Response Modif 2005;22:471–483.

    PubMed  Google Scholar 

  13. Maggard MA, O’Connell JB, Ko CY. Updated populationbased review of carcinoid tumors. Ann Surg 2 2004;240:117–122.

    Article  Google Scholar 

  14. Pinchot S, Holen K, Sippel R, Chen H. Carcinoid Tumors. The Oncologist 2008;13:1255–1269.

    Article  PubMed  CAS  Google Scholar 

  15. Kloppel G, Anlauf M. Epidemiology, tumour biology and histopathological classification of neuroendocrine tumours of the gastrointestinal tract. Best Pract Res Clin Gastroenterol 2005;19:507–517.

    Article  PubMed  Google Scholar 

  16. Delle Fave G, Capurso G, Milione M, et al. Endocrine tumours of the stomach. Best Pract Res Clin Gastroenterol 2005;19:659–673.

    Article  Google Scholar 

  17. Bordi C, Caruana P, D’Adda T, Azzoni C. Smooth muscle cell abnormalities associated with gastric ECL cell carcinoids. Endocr Pathol 1 1995;6:103–113.

    Article  Google Scholar 

  18. Havu N. Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion. Digestion 1986;35(suppl 1):42–55.

    Article  PubMed  Google Scholar 

  19. Ruszniewski P, Delle Fave G, Cadiot G, Komminoth P, Chung D, Kos-Kudla B, Kianmanesh R, Hochhauser D, Arnold R, Ahlman H, Pauwels S, Kwekkeboom DJ, Rindi G; Frascati Consensus Conference; European neuroendocrine Tumor Society. Well-differentiated gastric tumors/carcinomas. Neuroendocrinology 2006;84:158–164.

    Article  PubMed  CAS  Google Scholar 

  20. Burkitt MD, Pritchard DM. Review article: pathogenesis and management of gastric carcinoid tumours. Aliment Pharmacol Ther 2006;24:1305–1320.

    Article  PubMed  CAS  Google Scholar 

  21. Woodside KJ, Townsend CM, Mark EB. Current management of gastrointestinal carcinoid tumors. J Gastrointest Surg 2004;8:742–756.

    Article  PubMed  Google Scholar 

  22. Roncoroni L, Costi R, Canavese G, Violi V, Bordi C. Carcinoid tumor associated with vascular malformation as a cause of massive gastric bleeding. Am J Gastroenterol 1997;92:2119–2121.

    PubMed  CAS  Google Scholar 

  23. Dallal HJ, Ravindran R, King PM, Phull PS. Gastric carcinoid tumour as a cause of severe upper gastrointestinal haemorrhage. Endoscopy 2003;35:716.

    Article  PubMed  CAS  Google Scholar 

  24. Bordi C, D’Adda T, Azzoni C, Canavese G, Brandi ML. Gastrointestinal endocrine tumors: Recent developments. Endocr Pathol 1 1998;9:99–115.

    Article  Google Scholar 

  25. Annibale B, Lahner E, Negrini R, Baccini F, Bordi C, Monarca B, Delle Fave G. Lack of specific association between gastric autoimmunity hallmarks and clinical presentations of atrophic body gastritis. World J Gastroenterol 2005;11:5351–5357.

    PubMed  Google Scholar 

  26. Levy A, Sobin LH. Gastrointestinal Carcinoids: Imaging Features with Clinicopathologic Comparison. RadioGraphics 2007;27:237–257.

    Article  PubMed  Google Scholar 

  27. Binstock AJ, Johnson CD, Stephens DH, Lloyd RV, Fletcher JG. Carcinoid tumors of the stomach: a clinical and radiographic study. AJR Am J Roentgenol 2001;176(4):947–951.

    PubMed  CAS  Google Scholar 

  28. Berger MW, Stephens DH. Gastric carcinoid tumors associated with chronic hypergastrinemia in a patient with Zollinger-Ellison syndrome. Radiology 1996;201(2):371–373.

    PubMed  CAS  Google Scholar 

  29. Ba-Ssalamah A, Prokop M, Uffmann M, Pokieser P, Teleky B, Lechner G. Dedicated multidetector CT of the stomach: spectrum of diseases. Radio-Graphics 2003;23(3):625–644.

    Google Scholar 

  30. Bordi C, Azzoni C, Ferraro G, Corleto VD, Gibril F, Delle Fave G, Lubensky IA, Venzon DJ, Jensen RT. Sampling strategies for analysis of enterochromaffin-like cell changes in Zollinger-Ellison syndrome. Am J Clin Pathol 2000, 114:419–425.

    PubMed  CAS  Google Scholar 

  31. Bordi C, Corleto VD, Azzoni C, Pizzi S, Ferraro G, Gibril F, Delle Fave G, Jensen RT. The antral mucosa as a new site for endocrine tumors in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndromes. J Clin Endocrinol Metab 2001;86:2236–2242.

    Article  PubMed  CAS  Google Scholar 

  32. Giovannini M, Seitz JF, Thomas P, Houvenaeghel G, Delpero JR, Giudicelli R, Fuentes P. Endoscopic ultrasound examination using a curved-array transducer in benign and malignant diseases of the stomach-results in 30 patients. Gastroenterol Clin Biol 1993, 17:26–32.

    PubMed  CAS  Google Scholar 

  33. Vander Noot MR 3rd, Eloubeidi MA, Chen VK, Eltoum I, Jhala D, Jhala N, Syed S, Chhieng DC. Diagnosis of gastrointestinal tract lesions by endoscopic ultrasound-guided fine-needle aspiration biopsy. Cancer 2004, 102:157–163.

    Article  Google Scholar 

  34. Mulkeen A, Cha C. Gastric carcinoid. Curr Opin Oncol 2005;17:1–6.

    Article  PubMed  Google Scholar 

  35. Lamberts SW, Bakker WH, Reubi JC, Krenning EP. Somatostatin-receptor imaging in the localization of endocrine tumors. N Engl J Med 1990;323:1246–1249.

    Article  PubMed  CAS  Google Scholar 

  36. Orlefors H, Sundin A, Lu L, Oberg K, Lingström B, Eriksson B, Bergström M. Carbidopa pretreatment improves image interpretation and visualisation of carcinoid tumours with (11)C-5-hydroxytryptophan positron emission tomography. Eur J Nucl Med Mol Imaging 2006;33:60–65.

    Article  PubMed  CAS  Google Scholar 

  37. Ichikawa J, Tanabe S, Koizumi W, Kida Y, Imaizumi H, Kida M, Saigenji K, Mitomi H. Endoscopic mucosal resection in the management of gastric carcinoid tumors. Endoscopy 2003;35:203–206.

    Article  PubMed  CAS  Google Scholar 

  38. Kaehler G, Grobholz R, Langner C, Suchan K, Post S. A new technique of endoscopic full-thickness resection using a flexible stapler. Endoscopy 2006;38:86–89.

    Article  PubMed  CAS  Google Scholar 

  39. Hou W, Schubert ML. Treatment of gastric carcinoids. Curr Treat Options Gastroenterol 2007;10:123–133.

    Article  PubMed  Google Scholar 

  40. Kern SE, Yardley JH, Lazenby AJ, Boitnott JK, Yang VW, Bayless TM, Sitzmann JV. Reversal by antrectomy of endocrine cell hyperplasia in the gastric body in pernicious anemia: a morphometric study. Mod Pathol 1990;3:561–566.

    PubMed  CAS  Google Scholar 

  41. D’Adda T, Pilato FP, Sivelli R, Azzoni C, Sianesi M, Bordi C. Gastric carcinoid tumor and its precursor lesions. Ultrastructural study of a case before and after antrectomy. Arch Pathol Lab Med 1 1994;118:658–663.

    Google Scholar 

  42. Hirschowitz BI, Griffith J, Pellegrin D, Cummings OW. Rapid regression of enterochromaffin like cell gastric carcinoids in pernicious anemia after antrectomy. Gastroenterology 1992;102:1409–1418.

    PubMed  CAS  Google Scholar 

  43. Richards ML, Gauger P, Thompson NW, Giordano TJ. Regression of type II gastric carcinoids in multiple endocrine neoplasia type 1 patients with Zollinger-Ellison syndrome after surgical excision of all gastrinomas. World J Surg 2004;28:652–658.

    Article  PubMed  Google Scholar 

  44. Schindl M, Kaserer K, Niederle B. Treatment of gastric neuroendocrine tumors: the necessity of a type-adapted treatment. Arch Surg 2001;136:49–54.

    Article  PubMed  CAS  Google Scholar 

  45. Rindi G, Bordi C, Rappel S, La Rosa S, Stolte M, Solcia E. Gastric carcinoids and neuroendocrine carcinomas: Pathogenesis, pathology, and behavior. World J Surg 1996;20:168–172.

    Article  PubMed  CAS  Google Scholar 

  46. Borch K, Ahren B, Ahlman H, Falkmer S, Grimelius L. Gastric Carcinoids. Biologic Behavior and Prognosis After Differentiated Treatment in Relation to Type. Ann Surg 2005;242:64–73.

    Article  PubMed  Google Scholar 

  47. Soga J. Early-Stage Carcinoids of the Gastrointestinal Tract. Cancer 2005;103:1587–1595.

    Article  PubMed  Google Scholar 

  48. Hoffmann M, Furukawa M, Jensen RT. Duodenal neuroendocrine tumors: Classification, functional syndromes, diagnosis and medical treatment. Best Pract Res Clinical Gastroenter 2005;19:675–697.

    Article  CAS  Google Scholar 

  49. Kloppel G, Perren A & Heitz PU. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann N Y Acad Sci 2004;1014:13–27.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. Papageorgiou.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Papageorgiou, G., Lolis, E. Gastric and duodenal carcinoid tumours. Prevalence, tumour biology, diagnosis and surgical therapy. Hellenic J Surg 83, 4–11 (2011). https://doi.org/10.1007/s13126-011-0001-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13126-011-0001-x

Keywords

Navigation